glp-1 and crohn's disease The role of RA in inflammatory bowel disease. The GLP-1 RA GLP-1s and Crohn's Disease: Safety,

Most users experience bloating, gas, or temporary digestive changes during the initial adjustment period

IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep Publication: American Journal of Physiology-Endocrinology and Metabolism Volume 328, Issue 1 Abstract Insulin-like growth factor-1 (IGF-1) and insulin are important fetal anabolic hormones

R., Busby-Whitehead, J., Tsiao, C., Stewart, K

My name is Kathy, I am a retired high school English teacher & vegan enthusiast and blogger

In the SURMOUNT-5 trial, tirzepatide produced an average weight reduction of 20.2% (about 50 lbs) over 72 weeks, compared with 13.7% (about 33 lbs) for injectable semaglutide

Albiglutide is generated from a genetic fusion of two modified recombinant GLP-1 (36) molecules linked in tandem to recombinant human albumin (90), while dulaglutide is created by conjugating two GLP-1 (37) analogues to the Fc fragment of a modified monoclonal antibody (IgG4) via peptide ((Gly 4 Ser) 3 Ala) linker (91)